發(fā)布時(shí)間：2018-03-17 04:37

  本文選題：銀屑病　切入點(diǎn)：角質(zhì)形成細(xì)胞　出處：《中南大學(xué)》2012年博士論文　論文類型：學(xué)位論文

【摘要】：目的 CD147是一種屬于免疫球蛋白超家族的細(xì)胞膜表面高糖基化蛋白,其在表皮中的表達(dá)對(duì)銀屑病的發(fā)生發(fā)展具有促進(jìn)作用。ABCG2是ATP結(jié)合轉(zhuǎn)運(yùn)蛋白超家族成員之一,主要行使將多種化療藥物泵出細(xì)胞外的功能,進(jìn)而降低細(xì)胞對(duì)藥物的敏感性。近年已有文章報(bào)道ABCG2與角質(zhì)形成細(xì)胞的增殖相關(guān),但其在銀屑病角質(zhì)形成細(xì)胞中的分布及功能目前尚不清楚。本文旨在探討CD147與ABCG2在銀屑病表皮和HaCaT細(xì)胞中的表達(dá)、分布及相互調(diào)控,為進(jìn)一步揭示銀屑病的致病機(jī)制提供理論依據(jù)。 方法 (1)免疫組化分析CD147與ABCG2在銀屑病皮損表皮中的表達(dá)及分布； (2)冰凍切片激光共聚焦方法分析CD147與ABCG2在銀屑病皮損表皮的位置關(guān)系； (3)構(gòu)建穩(wěn)定轉(zhuǎn)染CD147的HaCaT細(xì)胞株(HaCaT-C)及米托葸醌(mitoxantrone, MX)誘導(dǎo)高表達(dá)ABCG2的HaCaT細(xì)胞株(HaCaT-A), Western blot方法鑒定穩(wěn)定株的構(gòu)建； (4)免疫沉淀(Immunoprecipitation, IP)檢測(cè)CD147與ABCG2在HaCaT-A中是否形成復(fù)合物； (5)利用HEK293FT細(xì)胞共轉(zhuǎn)染高表達(dá)ABCG2質(zhì)粒及不同CD147片段質(zhì)粒,IP分析ABCG2與CD147相互結(jié)合位點(diǎn)； (6) Western blot檢測(cè)MX誘導(dǎo)的ABCG2在HaCaT-C及對(duì)照組HaCaT細(xì)胞株(HaCaT-N)的表達(dá)差異； (7)采用Alarm blue染色方法分析HaCaT-C及HaCaT-N對(duì)MX的敏感性(IC50)； (8) Western blot分析TNF-α及對(duì)照組PBS誘導(dǎo)HaCaT細(xì)胞株中CD147與ABCG2表達(dá)水平的差異。 結(jié)果 (1)銀屑病皮損與正常皮膚相比,CD147及ABCG2在銀屑病角質(zhì)形成細(xì)胞中的表達(dá)全層上調(diào),并且主要表達(dá)在細(xì)胞膜； (2)激光共聚焦發(fā)現(xiàn)銀屑病皮損角質(zhì)形成細(xì)胞中CD147與ABCG2存在共定位現(xiàn)象； (3)成功構(gòu)建高表達(dá)CD147的HaCaT-C及高表達(dá)ABCG2的HaCaT-A細(xì)胞株； (4)IP顯示CD147與ABCG2在HaCaT-A細(xì)胞中以復(fù)合物形式存在； (5)成功建立共同轉(zhuǎn)染ABCG2質(zhì)粒及不同CD147片段質(zhì)粒的8組293FT細(xì)胞,IP揭示CD147與ABCG2結(jié)合位點(diǎn)位于CD147跨膜區(qū)； (6)MX誘導(dǎo)HaCaT-C細(xì)胞株中ABCG2的表達(dá)為對(duì)照組HaCaT-N細(xì)胞株的1.56±0.16倍。(P0.05)； (7) HaCaT-C細(xì)胞株對(duì)MX的敏感性顯著低于對(duì)照組HaCaT-N細(xì)胞株,IC50分別為6.83+0.14nM,3.20+0.17nM(P0.05),提示CD147對(duì)MX誘導(dǎo)的ABCG2(?)勺蛋白水平及藥物轉(zhuǎn)運(yùn)功能均有調(diào)控作用； (8)TNF-α誘導(dǎo)HaCaT細(xì)胞中ABCG2及CD147表達(dá)水平升高。 結(jié)論 (1)銀屑病皮損角質(zhì)形成細(xì)胞中CD147與ABCG2的表達(dá)增高并存在共定位現(xiàn)象； (2)CD147和ABCG2相結(jié)合,結(jié)合域位于CD147跨膜區(qū)； (3)CD147對(duì)ABCG2蛋白表達(dá)及功能具有調(diào)控作用。
[Abstract]:Purpose. CD147 is a highly glycosylated protein on the membrane surface of immunoglobulin superfamily. Its expression in epidermis promotes the development of psoriasis. ABCG2 is a member of ATP binding transporter superfamily. In recent years, it has been reported that ABCG2 is related to the proliferation of keratinocytes. The distribution and function of CD147 and ABCG2 in psoriatic keratinocytes are not clear. The purpose of this study is to investigate the expression, distribution and mutual regulation of CD147 and ABCG2 in psoriatic epidermis and HaCaT cells. To further reveal the pathogenesis of psoriasis to provide a theoretical basis. Method. The expression and distribution of CD147 and ABCG2 in the epidermis of psoriatic lesions were analyzed by immunohistochemistry. (2) the relationship between CD147 and ABCG2 in the epidermis of psoriasis was analyzed by laser confocal method. Construction of stable HaCaT cell line transfected with CD147 and mitoxantrone induced by mitoxantrone (MXX) induced by high ABCG2 expression in HaCaT cell line HaCaT-An. The construction of stable cell line was identified by Western blot method. (4) Immunoprecipitation (IP) of CD147 and ABCG2 in HaCaT-A; (5) HEK293FT cells were cotransfected with high expression ABCG2 plasmids and different CD147 fragment plasmids IP to analyze the interaction sites between ABCG2 and CD147. Western blot was used to detect the expression of MX-induced ABCG2 in HaCaT-C and control HaCaT cell line HaCaT-N. The sensitivity of HaCaT-C and HaCaT-N to MX was analyzed by Alarm blue staining. Western blot was used to analyze the expression of CD147 and ABCG2 in HaCaT cells induced by TNF- 偽 and PBS. Results. 1) the expression of CD147 and ABCG2 in psoriatic keratinocytes was up-regulated in the whole layer compared with normal skin, and mainly in the cell membrane of psoriatic keratinocytes. (2) CD147 and ABCG2 in keratinocytes of psoriatic lesions were found to be co-localized by laser confocal focusing. (3) HaCaT-C with high expression of CD147 and HaCaT-A cell line with high expression of ABCG2 were successfully constructed. The expression of CD147 and ABCG2 in HaCaT-A cells was found in the form of complex. 5) eight groups of 293FT cells cotransfected with ABCG2 plasmids and different CD147 fragments were successfully constructed to reveal that the binding sites of CD147 and ABCG2 were located in the transmembrane region of CD147. The expression of ABCG2 was 1.56 鹵0.16 times higher than that of the control HaCaT-N cell line, and the expression of ABCG2 was 1.56 鹵0.16 times higher than that of the control HaCaT-N cell line. The sensitivity of HaCaT-C cell line to MX was significantly lower than that of control HaCaT-N cell line (6.83 0.14nMN) 3.20 0.17nMN P0.05A, which suggested that CD147 was sensitive to MX-induced ABCG2? ) Dipper protein level and drug transport function can be regulated. TNF- 偽 induced increased expression of ABCG2 and CD147 in HaCaT cells. Conclusion. 1) the expression of CD147 and ABCG2 in keratinocytes of psoriatic lesions increased and co-located. The binding domain of CD147 and ABCG2 is located in the transmembrane region of CD147. CD147 can regulate the expression and function of ABCG2 protein.
【學(xué)位授予單位】：中南大學(xué)
【學(xué)位級(jí)別】：博士
【學(xué)位授予年份】：2012
【分類號(hào)】：R758.63

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 ;異體皮膚穴位移植埋藏治療銀屑病[J];陜西醫(yī)學(xué)雜志;1977年01期

2 白忠林;肖淑芬;李連仲;;銀屑病治療藥物介紹[J];黑龍江醫(yī)學(xué);1980年01期

3 許月林;;銀屑病中的同形反應(yīng)[J];國(guó)際皮膚性病學(xué)雜志;1984年04期

4 張忠祥;;關(guān)于銀屑病發(fā)病因素的探討[J];青海醫(yī)學(xué)院學(xué)報(bào);1986年01期

5 王永賢;;治療對(duì)銀屑病中調(diào)鈣蛋白水平的影響[J];國(guó)際皮膚性病學(xué)雜志;1987年05期

6 湖北省銀屑病調(diào)查組;湖北省銀屑病流行病學(xué)調(diào)查[J];華中科技大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);1988年03期

7 全國(guó)銀屑病流行調(diào)查組;邵長(zhǎng)庚;張國(guó)威;包寅德;蔣仲元;韓國(guó)柱;顧恒;;全國(guó)1984年銀屑病流行調(diào)查報(bào)告[J];皮膚病與性病;1989年01期

8 包寅德;曹元華;陳素玲;陶明波;徐建平;邵長(zhǎng)庚;;江蘇省泰州市及周?chē)h八個(gè)鄉(xiāng)的銀屑病流行情況的調(diào)查報(bào)告[J];皮膚病與性病;1990年02期

9 耿建麗;;痣樣銀屑病[J];國(guó)際皮膚性病學(xué)雜志;1990年03期

10 Barkef JNWN;李春元;;銀屑病的病理生理學(xué)[J];國(guó)際皮膚性病學(xué)雜志;1992年04期

相關(guān)會(huì)議論文 前10條

1 閻衡;葉慶佾;郝飛;黃東平;唐書(shū)謙;黃秀英;張黎;;銀屑病患者外周血單個(gè)核細(xì)胞中CTLA_4mRNA及蛋白的表達(dá)[A];2001年中國(guó)中西醫(yī)結(jié)合皮膚性病學(xué)術(shù)會(huì)議論文匯編[C];2001年

2 陳明星;姚亞南;王愛(ài)民;金群;;銀康顆粒劑治療銀屑病252例臨床觀察[A];全國(guó)中藥研究學(xué)術(shù)討論會(huì)論文集[C];2003年

3 王冬云;彭振輝;譚升順;楚瑞奇;劉平;馬慧群;張盤(pán)諫;;PML表達(dá)在銀屑病發(fā)病機(jī)理中的作用[A];2003中國(guó)中西醫(yī)結(jié)合皮膚性病學(xué)術(shù)會(huì)議論文匯編[C];2003年

4 趙艷霞;陳學(xué)榮;李東明;;單味中藥及其提取制劑治療銀屑病的臨床應(yīng)用[A];2003中國(guó)中西醫(yī)結(jié)合皮膚性病學(xué)術(shù)會(huì)議論文匯編[C];2003年

5 唐雋;郝飛;;銀屑病治療的評(píng)價(jià)[A];中華醫(yī)學(xué)會(huì)第14次全國(guó)皮膚性病學(xué)術(shù)年會(huì)論文匯編[C];2008年

6 楊佃會(huì);王健;單秋華;趙穎;韓晶;;耳穴綜合療法治療穩(wěn)定期銀屑病的臨床療效觀察[A];2011中國(guó)針灸學(xué)會(huì)年會(huì)論文集（摘要）[C];2011年

7 鄭敏;滿孝勇;李偉;周炯;陳佳琦;李春明;蔡綏R，

本文編號(hào)：1623233